Editorial to the Second Issue Dedicated to Lewis Sheiner Malcolm Rowland EditorialNotes 09 May 2006 Pages: 223 - 225
Pharmacokinetic–Pharmacodynamic Modelling: History and Perspectives Chantal CsajkaDavide Verotta OriginalPaper 11 January 2006 Pages: 227 - 279
Disease Progression and Pharmacodynamics in Parkinson Disease – Evidence for Functional Protection with Levodopa and Other Treatments Nicholas H. G. HolfordPhylinda L. S. ChanParkinson Study Group OriginalPaper 20 April 2006 Pages: 281 - 311
A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus Willem de WinterJoost DeJonghMeindert Danhof OriginalPaper 22 March 2006 Pages: 313 - 343
Prediction Discrepancies for the Evaluation of Nonlinear Mixed-Effects Models France MentréSylvie Escolano OriginalPaper 13 November 2005 Pages: 345 - 367
Model-Based Drug Development: The Road to Quantitative Pharmacology Liping ZhangVikram SinhaSandra R. B. Allerheiligen OriginalPaper 13 June 2006 Pages: 369 - 393